Organization Overview
Alternative names
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
bifidobacterium bifidum (1 trial)
bifidobacterium lactis (1 trial)
bovine plasma protein (1 trial)
cannabidiol (Epidiolex) (1 trial)
enterococcus faecium w54 (1 trial)
fructo-oligosaccharide (2 trials)
galactooligosaccharide (3 trials)
gamma-aminobutyric acid (1 trial)
Cognitive Dysfunction (Phase 1)
Delirium (Phase 4)
Malaria (Phase 4)
Osteoporosis (Phase 1)
Psychomotor Agitation (Phase 4)
Substance Withdrawal Syndrome (Phase 4)
Vitamin D Deficiency (Phase 3)